<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><issn pub-type="epub">3033-8344</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2026-7-3-23-33</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-763</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Разработка модели машинного обучения для прогнозирования артериальной гипертензии на основе показателей клинического анализа крови</article-title><trans-title-group xml:lang="en"><trans-title>Development of a machine-learning model for predicting arterial hypertension based on complete blood count parameters</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8220-351X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарчук</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharchuk</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захарчук Софья Александровна, студент, факультет фундаментальной медицины</p><p>Москва</p></bio><bio xml:lang="en"><p>Sofya A. Zakharchuk, student, Faculty of Medicine</p><p>Moscow</p></bio><email xlink:type="simple">szakharchuk5@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6729-4371</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронов</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironov</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронов Никита Александрович, к. м. н., ассистент кафедры терапии, старший научный сотрудник </p><p>Москва</p></bio><bio xml:lang="en"><p>Nikita A. Mironov, Cand. Sci. (Med.), Assistant Professor, Senior Researcher</p><p>Moscow</p></bio><email xlink:type="simple">nikimir29@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2015-4712</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плисюк</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Plisyuk</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плисюк Алина Геннадьевна, к. м. н., доцент кафедры терапии</p><p>Москва</p></bio><bio xml:lang="en"><p>Alina G. Plisyuk, Cand. Sci. (Med.), Associate Professor</p><p>Moscow</p></bio><email xlink:type="simple">apl.cardio@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8160-5612</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлова</surname><given-names>Я. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlova</surname><given-names>Ya. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орлова Яна Артуровна, д. м. н., проф., заведующий отделом возраст-ассоциированных заболеваний</p><p>Москва</p></bio><bio xml:lang="en"><p>Yana A. Orlova, Dr. Sci. (Med.), Professor, Head of the Department of Age-Associated Diseases</p><p>Moscow</p></bio><email xlink:type="simple">5163002@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский научно-образовательный институт Московского государственного университета им. М.В Ломоносова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Research and Educational Institute, Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2026</year></pub-date><volume>7</volume><issue>3</issue><fpage>23</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Захарчук С.А., Миронов Н.А., Плисюк А.Г., Орлова Я.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Захарчук С.А., Миронов Н.А., Плисюк А.Г., Орлова Я.А.</copyright-holder><copyright-holder xml:lang="en">Zakharchuk S.A., Mironov N.A., Plisyuk A.G., Orlova Y.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/763">https://www.therapeutic-j.ru/jour/article/view/763</self-uri><abstract><p>Цель: разработать и оценить модель машинного обучения для прогнозирования наличия артериальной гипертензии (АГ) по данным демографических показателей и параметров клинического анализа крови (КАК), а также определить вклад ключевых предикторов с использованием интерпретируемых методов. Материалы и методы: проанализирована база данных 5506 пациентов, последовательно обследованных в Университетской клинике Медицинского научно-образовательного института (МНОИ) МГУ им. М.В. Ломоносова в 2021–2022 гг. (2256 мужчин и 3250 женщин, со средним возрастом 57,23±17,60 лет). АГ выявлена у 3697 (67%) обследованных, 1809 (33%) составили группу без АГ. В качестве переменных использовали пол, возраст, показатели КАК и производные воспалительные индексы (нейтрофильно-лимфоцитарное отношение (NLR), лимфоцитарно-моноцитарное отношение (LMR), тромбоцитарнолимфоцитарное отношение (PLR)). Сравнивали разработанную стекинг-модель и модели Lasso и Ridge-регрессии, логистическую регрессию, случайный лес, градиентный бустинг. Качество оценивали по площади под ROC-кривой (AUC). Результаты: AUC составила 0,75–0,77 для отдельных моделей, тогда как стекинг-модель продемонстрировала AUC 0,99 на отложенной тестовой выборке. Разница AUC между стекинг-моделью и альтернативными подходами была статистически значимой (p&lt;0,001), средний прирост относительно логистической регрессии составил 22,9 % (абсолютная разница AUC). Ведущими маркерами стали возраст и эритроцитарные индексы RDW-SD, MCV, HGB и MCH. Заключение: по результатам внутренней валидации использование ансамблевых методов машинного обучения с включением показателей КАК может повысить дискриминационную способность моделей прогнозирования сердечно-сосудистых заболеваний, однако полученные оценки качества требуют подтверждения при внешней валидации на независимой когорте. Возраст и эритроцитарные индексы (RDW-SD, MCV, HGB, MCH) являются наиболее информативными предикторами АГ и могут рассматриваться как доступные маркерные кандидаты для дальнейших исследований и совершенствования стратификации риска.</p></abstract><trans-abstract xml:lang="en"><p>Objective: development and evaluation of a machine learning model for predicting arterial hypertension using demographic characteristics and complete blood count parameters, and to assess the contribution of key predictors using interpretable methods. Materials and methods: we analyzed a dataset of 5,506 patients examined at the University Clinic of the Medical Research and Educational Institute of Lomonosov Moscow State University in 2021–2022 (2,256 men and 3,250 women, mean age 57.23±17.60 years). Arterial hypertension was identified in 3,697 (67%) individuals, while 1,809 (33%) formed the nonhypertensive group. Variables included sex, age, complete blood count parameters, and derived inflammatory indices (NLR, LMR, PLR). The proposed stacking model was compared with Lasso and Ridge regression, logistic regression, random forest, and gradient boosting. Model performance was assessed using the AUC. Results: AUC ranged from 0.75 to 0.77 for classic machine learning models, whereas the stacking model achieved an AUC of 0.99. The difference in AUC between the stacking model and alternative approaches was statistically significant (p&lt;0.001), with a mean improvement of 22.9% compared with logistic regression. The leading markers were age and the erythrocyte indices RDW-SD, MCV, HGB, and MCH. Conclusion: based on internal validation, ensemble machine learning methods incorporating complete blood count parameters may improve the discriminative performance of cardiovascular risk prediction models; however, these performance estimates require confirmation through external validation in an independent cohort. Age and erythrocyte indices (RDW-SD, MCV, HGB, MCH) were the most informative predictors of arterial hypertension and may serve as accessible marker candidates for further research and improved risk stratification.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>машинное обучение</kwd><kwd>клинический анализ крови</kwd><kwd>стратификация сердечно-сосудистого риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>machine learning</kwd><kwd>complete blood count</kwd><kwd>cardiovascular risk stratification</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания Московского государственного университета им. М.В. Ломоносова.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Obermeyer Z, Emanuel EJ. Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016;375(13):1216-1219. DOI: 10.1056/NEJMp1606181</mixed-citation><mixed-citation xml:lang="en">Obermeyer Z, Emanuel EJ. Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016;375(13):1216-1219. DOI: 10.1056/NEJMp1606181</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chen JH, Asch SM. Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. N Engl J Med. 2017;376(26):2507-2509. DOI: 10.1056/NEJMp1702071</mixed-citation><mixed-citation xml:lang="en">Chen JH, Asch SM. Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. N Engl J Med. 2017;376(26):2507-2509. DOI: 10.1056/NEJMp1702071</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform. 2018;19(6):1236-1246. DOI: 10.1093/bib/bbx044</mixed-citation><mixed-citation xml:lang="en">Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform. 2018;19(6):1236-1246. DOI: 10.1093/bib/bbx044</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115-118. Erratum in: Nature. 2017;546(7660):686. DOI: 10.1038/nature21056</mixed-citation><mixed-citation xml:lang="en">Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115-118. Erratum in: Nature. 2017;546(7660):686. DOI: 10.1038/nature21056</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao H, Zhang X, Xu Y, Gao L, Ma Z, Sun Y, et al. Predicting the Risk of Hypertension Based on Several Easy-to-Collect Risk Factors: A Machine Learning Method. Front Public Health. 2021;9:619429. DOI: 10.3389/fpubh.2021.619429</mixed-citation><mixed-citation xml:lang="en">Zhao H, Zhang X, Xu Y, Gao L, Ma Z, Sun Y, et al. Predicting the Risk of Hypertension Based on Several Easy-to-Collect Risk Factors: A Machine Learning Method. Front Public Health. 2021;9:619429. DOI: 10.3389/fpubh.2021.619429</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54(10):979-985. DOI: 10.1016/s0895-4356(01)00372-9</mixed-citation><mixed-citation xml:lang="en">Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54(10):979-985. DOI: 10.1016/s0895-4356(01)00372-9</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Boateng EY, Abaye DA. A Review of the Logistic Regression Model with Emphasis on Medical Research. J Data Anal Inf Process. 2019;7(4):190-207. DOI: 10.4236/jdaip.2019.74012</mixed-citation><mixed-citation xml:lang="en">Boateng EY, Abaye DA. A Review of the Logistic Regression Model with Emphasis on Medical Research. J Data Anal Inf Process. 2019;7(4):190-207. DOI: 10.4236/jdaip.2019.74012</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. DOI: 10.1186/s12889-021-10429-0</mixed-citation><mixed-citation xml:lang="en">Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. DOI: 10.1186/s12889-021-10429-0</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-e528. Erratum in: Circulation. 2020;141(2):e33. DOI: 10.1161/CIR.0000000000000659.</mixed-citation><mixed-citation xml:lang="en">Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-e528. Erratum in: Circulation. 2020;141(2):e33. DOI: 10.1161/CIR.0000000000000659.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ma LY, Chen WW, Gao RL, Liu LS, Zhu ML, Wang YJ, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol. 2020;17(1):1-8. DOI: 10.11909/j.issn.1671-5411.2020.01.001</mixed-citation><mixed-citation xml:lang="en">Ma LY, Chen WW, Gao RL, Liu LS, Zhu ML, Wang YJ, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol. 2020;17(1):1-8. DOI: 10.11909/j.issn.1671-5411.2020.01.001</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Coronado F, Melvin SC, Bell RA, Zhao G. Global Responses to Prevent, Manage, and Control Cardiovascular Diseases. Prev Chronic Dis. 2022;19:E84. DOI: 10.5888/pcd19.220347</mixed-citation><mixed-citation xml:lang="en">Coronado F, Melvin SC, Bell RA, Zhao G. Global Responses to Prevent, Manage, and Control Cardiovascular Diseases. Prev Chronic Dis. 2022;19:E84. DOI: 10.5888/pcd19.220347</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. Erratum in: Eur Heart J. 2021;42(48):4901. DOI: 10.1093/eurheartj/ehab368.</mixed-citation><mixed-citation xml:lang="en">McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. Erratum in: Eur Heart J. 2021;42(48):4901. DOI: 10.1093/eurheartj/ehab368.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356- 75. DOI: 10.1161/CIRCULATIONAHA.107.182882</mixed-citation><mixed-citation xml:lang="en">Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356- 75. DOI: 10.1161/CIRCULATIONAHA.107.182882</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dobesh PP, Finks SW, Trujillo TC. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events. Clin Ther. 2020;42(10):2084-2097. DOI: 10.1016/j.clinthera.2020.08.003</mixed-citation><mixed-citation xml:lang="en">Dobesh PP, Finks SW, Trujillo TC. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events. Clin Ther. 2020;42(10):2084-2097. DOI: 10.1016/j.clinthera.2020.08.003</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ерина А.М., Ротарь О.П., Солнцев В.Н., Шальнова С.А., Деев А.Д., Баранова Е.И., и др. Эпидемиология артериальной гипертензии в Российской Федерации – важность выбора критериев диагностики. Кардиология. 2019;59(6):5-11.</mixed-citation><mixed-citation xml:lang="en">Ерина А.М., Ротарь О.П., Солнцев В.Н., Шальнова С.А., Деев А.Д., Баранова Е.И., и др. Эпидемиология артериальной гипертензии в Российской Федерации – важность выбора критериев диагностики. Кардиология. 2019;59(6):5-11.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6117.</mixed-citation><mixed-citation xml:lang="en">Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6117.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ротарь О.П., Ильянова И.Н., Бояринова М.А., Могучая Е.В., Толкунова К.М., Дьячков В.А., и др. Результаты Всероссийского скрининга артериальной гипертензии 2023. Российский кардиологический журнал. 2024;29(5):5931.</mixed-citation><mixed-citation xml:lang="en">Ротарь О.П., Ильянова И.Н., Бояринова М.А., Могучая Е.В., Толкунова К.М., Дьячков В.А., и др. Результаты Всероссийского скрининга артериальной гипертензии 2023. Российский кардиологический журнал. 2024;29(5):5931.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Layton AT. AI, Machine Learning, and ChatGPT in Hypertension. Hypertension. 2024;81(4):709-716. DOI: 10.1161/HYPERTENSIONAHA.124.19468</mixed-citation><mixed-citation xml:lang="en">Layton AT. AI, Machine Learning, and ChatGPT in Hypertension. Hypertension. 2024;81(4):709-716. DOI: 10.1161/HYPERTENSIONAHA.124.19468</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Islam SMS, Talukder A, Awal MA, Siddiqui MMU, Ahamad MM, Ahammed B, et al. Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries. Front Cardiovasc Med. 2022;9:839379. DOI: 10.3389/fcvm.2022.839379</mixed-citation><mixed-citation xml:lang="en">Islam SMS, Talukder A, Awal MA, Siddiqui MMU, Ahamad MM, Ahammed B, et al. Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries. Front Cardiovasc Med. 2022;9:839379. DOI: 10.3389/fcvm.2022.839379</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Khamissi FZ, Sun L, Johnson P, Shah S, Benjamin IJ. Machine Learning and Artificial Intelligence for Research on Hypertension. Am J Hypertens. 2025;38(11):867-871. DOI: 10.1093/ajh/hpaf051</mixed-citation><mixed-citation xml:lang="en">Khamissi FZ, Sun L, Johnson P, Shah S, Benjamin IJ. Machine Learning and Artificial Intelligence for Research on Hypertension. Am J Hypertens. 2025;38(11):867-871. DOI: 10.1093/ajh/hpaf051</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024;21(6):396-416. DOI: 10.1038/s41569-023-00964-1</mixed-citation><mixed-citation xml:lang="en">Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024;21(6):396-416. DOI: 10.1038/s41569-023-00964-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Мордовин В.Ф., Зюбанова И.В., Манукян М.А., Доржиева И.К., Вторушина А.А., Хунхинова С.А., и др. Роль иммуновоспалительных механизмов в патогенезе артериальной гипертонии. Сибирский журнал клинической и экспериментальной медицины. 2023;38(1):21-27.</mixed-citation><mixed-citation xml:lang="en">Мордовин В.Ф., Зюбанова И.В., Манукян М.А., Доржиева И.К., Вторушина А.А., Хунхинова С.А., и др. Роль иммуновоспалительных механизмов в патогенезе артериальной гипертонии. Сибирский журнал клинической и экспериментальной медицины. 2023;38(1):21-27.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Поселюгина О.Б., Коричкина Л.Н., Стеблецова Н.И., Бородина В.Н., Данилина К.С., Маслов А.Н., и др. Показатели клинического анализа крови у больных с эссенциальной и ренопаренхиматозной артериальной гипертензией. Трудный пациент. 2021;19(2):14-17.</mixed-citation><mixed-citation xml:lang="en">Поселюгина О.Б., Коричкина Л.Н., Стеблецова Н.И., Бородина В.Н., Данилина К.С., Маслов А.Н., и др. Показатели клинического анализа крови у больных с эссенциальной и ренопаренхиматозной артериальной гипертензией. Трудный пациент. 2021;19(2):14-17.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Драпкина О.М., Шляхто Е.В., Конради А.О., Баланова Ю.А., Жернакова Ю.В., и др. Исследование ЭССЕ-РФ (Эпидемиология сердечно-сосудистых заболеваний и их факторов риска в регионах Российской Федерации). Десять лет спустя. Кардиоваскулярная терапия и профилактика. 2021;20(5):3007.</mixed-citation><mixed-citation xml:lang="en">Бойцов С.А., Драпкина О.М., Шляхто Е.В., Конради А.О., Баланова Ю.А., Жернакова Ю.В., и др. Исследование ЭССЕ-РФ (Эпидемиология сердечно-сосудистых заболеваний и их факторов риска в регионах Российской Федерации). Десять лет спустя. Кардиоваскулярная терапия и профилактика. 2021;20(5):3007.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Schjerven FE, Ingeström EML, Steinsland I, Lindseth F. Development of risk models of incident hypertension using machine learning on the HUNT study data. Sci Rep. 2024;14(1):5609. DOI: 10.1038/s41598-024-56170-7</mixed-citation><mixed-citation xml:lang="en">Schjerven FE, Ingeström EML, Steinsland I, Lindseth F. Development of risk models of incident hypertension using machine learning on the HUNT study data. Sci Rep. 2024;14(1):5609. DOI: 10.1038/s41598-024-56170-7</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhan YL, Zou B, Kang T, Xiong LB, Zou J, Wei YF. Multiplicative interaction between mean corpuscular volume and red cell distribution width with target organ damage in hypertensive patients. J Clin Lab Anal. 2017;31(5):e22082. DOI: 10.1002/jcla.22082</mixed-citation><mixed-citation xml:lang="en">Zhan YL, Zou B, Kang T, Xiong LB, Zou J, Wei YF. Multiplicative interaction between mean corpuscular volume and red cell distribution width with target organ damage in hypertensive patients. J Clin Lab Anal. 2017;31(5):e22082. DOI: 10.1002/jcla.22082</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circ Res. 2018;122(6):877-902. DOI: 10.1161/CIRCRESAHA.117.311401</mixed-citation><mixed-citation xml:lang="en">Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circ Res. 2018;122(6):877-902. DOI: 10.1161/CIRCRESAHA.117.311401</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Emamian M, Hasanian SM, Tayefi M, Bijari M, Movahedian Far F, Shafiee M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31(6):e22124. DOI: 10.1002/jcla.22124</mixed-citation><mixed-citation xml:lang="en">Emamian M, Hasanian SM, Tayefi M, Bijari M, Movahedian Far F, Shafiee M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31(6):e22124. DOI: 10.1002/jcla.22124</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis. 2015;7(10):E402-11. DOI: 10.3978/j.issn.2072-1439.2015.10.04</mixed-citation><mixed-citation xml:lang="en">Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis. 2015;7(10):E402-11. DOI: 10.3978/j.issn.2072-1439.2015.10.04</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Hou X, Zhong J, Liu K. Association between red cell distribution width and hypertension: Results from NHANES 1999-2018. PLoS One. 2024;19(5):e0303279. DOI: 10.1371/journal.pone.0303279</mixed-citation><mixed-citation xml:lang="en">Chen Y, Hou X, Zhong J, Liu K. Association between red cell distribution width and hypertension: Results from NHANES 1999-2018. PLoS One. 2024;19(5):e0303279. DOI: 10.1371/journal.pone.0303279</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">He Z, Chen Z, Wang Y, Qin H, Wu W, Fu P, et al. Individual and joint effects of red blood cell traits on hypertension: a longitudinal analysis. Eur J Prev Cardiol. 2026;33(7):1140-1150. DOI: 10.1093/eurjpc/zwaf093</mixed-citation><mixed-citation xml:lang="en">He Z, Chen Z, Wang Y, Qin H, Wu W, Fu P, et al. Individual and joint effects of red blood cell traits on hypertension: a longitudinal analysis. Eur J Prev Cardiol. 2026;33(7):1140-1150. DOI: 10.1093/eurjpc/zwaf093</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Миронов Н.А., Приезжев А.В., Свешникова А.Н., Луговцов А.Е., Каранадзе Н.А., Дячук Л.И., и др. Связь изменений микрореологии крови, системы гемостаза и функционального статуса пациентов с хронической сердечной недостаточностью: обоснование и протокол исследования. Кардиологический вестник. 2024;19(1):79-83.</mixed-citation><mixed-citation xml:lang="en">Миронов Н.А., Приезжев А.В., Свешникова А.Н., Луговцов А.Е., Каранадзе Н.А., Дячук Л.И., и др. Связь изменений микрореологии крови, системы гемостаза и функционального статуса пациентов с хронической сердечной недостаточностью: обоснование и протокол исследования. Кардиологический вестник. 2024;19(1):79-83.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yu S, Xiong L, Wei D, Zhu H, Cai X, Shao L, et al. Prediction of the left ventricular mass index in hypertensive patients using the product of red cell distribution width and mean corpuscular volume. Medicine (Baltimore). 2024;103(14):e37685. DOI: 10.1097/MD.0000000000037685</mixed-citation><mixed-citation xml:lang="en">Yu S, Xiong L, Wei D, Zhu H, Cai X, Shao L, et al. Prediction of the left ventricular mass index in hypertensive patients using the product of red cell distribution width and mean corpuscular volume. Medicine (Baltimore). 2024;103(14):e37685. DOI: 10.1097/MD.0000000000037685</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Williams SK, Ravenell J, Seyedali S, Nayef S, Ogedegbe G. Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines. Prog Cardiovasc Dis. 2016;59(3):282-288. DOI: 10.1016/j.pcad.2016.09.004</mixed-citation><mixed-citation xml:lang="en">Williams SK, Ravenell J, Seyedali S, Nayef S, Ogedegbe G. Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines. Prog Cardiovasc Dis. 2016;59(3):282-288. DOI: 10.1016/j.pcad.2016.09.004</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sheikhy A, Fallahzadeh A, Aghaei Meybodi HR, Hasanzad M, Tajdini M, Hosseini K. Personalized medicine in cardiovascular disease: review of literature. J Diabetes Metab Disord. 2021;20(2):1793-1805. DOI: 10.1007/s40200-021-00840-0</mixed-citation><mixed-citation xml:lang="en">Sheikhy A, Fallahzadeh A, Aghaei Meybodi HR, Hasanzad M, Tajdini M, Hosseini K. Personalized medicine in cardiovascular disease: review of literature. J Diabetes Metab Disord. 2021;20(2):1793-1805. DOI: 10.1007/s40200-021-00840-0</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563-e595. Erratum in: Circulation. 2019;140(11):e647-e648. Erratum in: Circulation. 2020;141(4):e59. Erratum in: Circulation. 2020;141(16):e773. DOI: 10.1161/CIR.0000000000000677</mixed-citation><mixed-citation xml:lang="en">Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563-e595. Erratum in: Circulation. 2019;140(11):e647-e648. Erratum in: Circulation. 2020;141(4):e59. Erratum in: Circulation. 2020;141(16):e773. DOI: 10.1161/CIR.0000000000000677</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227- 3337. Erratum in: Eur Heart J. 2022;43(42):4468. DOI: 10.1093/eurheartj/ehab484</mixed-citation><mixed-citation xml:lang="en">Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227- 3337. Erratum in: Eur Heart J. 2022;43(42):4468. DOI: 10.1093/eurheartj/ehab484</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
